The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.
第一作者:
Ling-Qun,Kong
第一单位:
Liver Cancer Institute and Zhongshan Hospital, Fudan University, the Key Laboratory for Carcinogenesis & Cancer Invasion, The Ministry of Education of China, Shanghai, PR China.
作者:
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗原, CD(Antigens, CD);抗原, 分化, 髓单核细胞(Antigens, Differentiation, Myelomonocytic);癌, 肝细胞(Carcinoma, Hepatocellular);队列研究(Cohort Studies);疾病恶化(Disease Progression);无病生存(Disease-Free Survival);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);女(雌)性(Female);流式细胞术(Flow Cytometry);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);免疫组织化学(Immunohistochemistry);肝肿瘤(Liver Neoplasms);巨噬细胞(Macrophages);男(雄)性(Male);中年人(Middle Aged);预后(Prognosis);受体, 细胞表面(Receptors, Cell Surface);青年人(Young Adult)
DOI
10.1371/journal.pone.0059771
PMID
23555776
发布时间
2025-01-03
- 浏览5
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



